DAILY MORNING NOTE | 23 February 2023

Singapore shares declined on Wednesday (Feb 22) along with major regional markets, after Wall Street saw its largest single-day fall in 2023 overnight. The Straits Times Index (STI) fell 0.2 per cent or 6.82 points to 3,300.04. Across the broader market, losers beat gainers 304 to 246 after 1.7 billion securities worth S$1.3 billion changed hands. Major Asian markets were in the red on Wednesday. Japan’s Nikkei 225 fell 1.3 per cent, Hong Kong’s Hang Seng Index shed 0.5 per cent and South Korea’s Kospi declined 1.7 per cent.

Wall Street stocks finished a choppy session mostly lower on Wednesday as markets assessed the significance of minutes from the last Federal Reserve meeting, which revealed that nearly all policy makers favoured a smaller interest rate hike. But since that Feb 1 meeting, January inflation and employment data have suggested that pricing pressures remain acute, stoking fears that the US central bank’s rate-hiking cycle could be prolonged. The Dow Jones Industrial Average ended down 0.3 per cent at 33,045.09. The broad-based S&P 500 shed 0.3 per cent to 3,991.05, while the tech-rich Nasdaq Composite Index added 0.1 per cent to 11,507.07.

Stocks to watch: UOB

Top gainers & losers





UOB’s 4Q2022 results were slightly lower than expectations with normalised net profit of S$1.40bn vs our estimate of S$1.59bn. This was mainly due to net interest income growth of 53% YoY (S$2.56bn) and other income growth of 62% YoY (S$285mn) offset by net fee income dipping 16% YoY (485mn) and higher allowances of S$184mn (+65% YoY). 4Q22 dividend is up 25% YoY to 75 cents, total FY22 dividend at 135 cents (+13% YoY). More details to follow after the 10.15am analyst call.

Shares in Sats fell as much as 4.4 per cent on Wednesday (Feb 22) after the inflight caterer and ground handler said it will issue 363.1 million new shares at S$2.20 apiece to raise around S$798.8 million via a renounceable underwritten rights issue. The number of new shares to be issued represents around 32.3 per cent of all existing issued shares. The counter tumbled to a low of S$2.63 – down S$0.12 from its previous close of S$2.75 – after Sats called for the trading halt to be lifted around noon. It regained some composure to close at S$2.72 on Wednesday, down 1.1 per cent or S$0.03, after 10 million shares changed hands.

The certificate of entitlement (COE) price in the Open category hit a record high of S$118,001 in the tender exercise that closed on Wednesday (Feb 22). The commercial vehicle COE also set a new record price of S$87,790, and the premiums for all other categories went up. The price for Open COE at S$118,001 represents an increase of 12.4 per cent from S$105,002 in the last tender exercise. This breaks the record of S$116,577 set in November 2022.

Local public transport operator SBS Transit, a 75%-owned company of ComfortDelGro, announced that its FY2022 ended Dec 31, 2022, earnings have increased by 31.7% to $68.0 million from $51.6 million a year ago. This comes on the back of a 15.6% y-o-y increase in revenue to $1.5 billion from $1.3 billion last year, with revenue contribution from both public transport services and other commercial services seeing growth. Revenue from the public transport services business, which comprises bus and rail services, increased by 15.8% y-o-y to $1.5 billion. This was due mainly to higher fuel indexation from higher oil prices, and higher rail revenue from increased ridership.

Healthcare services provider TalkMed Group’s net profit for the second half (H2) rose 28.7 per cent, thanks to higher revenue from more oncology patient visits in Singapore. Net profit for the six months ended Dec 31, 2022 rose to S$18.4 million, from S$14.3 million in the corresponding period in 2021. This was mainly due to an improvement in patient numbers – who came from around the region – following the easing of pandemic measures in Singapore last year, TalkMed said in a regulatory filing on Wednesday (Feb 22).

Google Asia-Pacific will give up part of the space it leases at Frasers Logistics & Commercial Trust’s (FLCT) Alexandra Technopark property from Feb 20, 2024, the real estate investment trust (Reit) manager said in a filing on Wednesday (Feb 22). The manager said the tech giant has exercised its contractual right to surrender a portion of its premises that it leases. The premises to be surrendered constitutes approximately 1.7 per cent of FLCT’s gross rental income (GRI) for the month ended Dec 31, 2022.

The manager of United Hampshire US Real Estate Investment Trust (United Hampshire US Reit) on Wednesday (Feb 22) posted distribution per unit (DPU) of US$0.0297 for the second half ended Dec 31, 2022, down 2.6 per cent from DPU of US$0.0305 the previous year. Excluding one-off top-ups and stipulated damages, adjusted DPU for H2 FY2022 would have been 5.7 per cent higher than the previous year. The H2 DPU of US$0.0297 will be paid on Mar 31. Distributable income rose 5.2 per cent to US$16.8 million in H2, from US$16 million in the year-ago period.

Boustead Singapore will raise the offer price to take its mainboard-listed real estate subsidiary Boustead Projects private to S$0.95 per share from S$0.90 previously, with the revised offer price final, Boustead Singapore said in a bourse filing on Wednesday (Feb 22). The announcement comes after investor protests on undervaluation. In a letter to Boustead Singapore on Feb 16, the Securities Investors Association (Singapore) (Sias) called on the engineering services provider to raise its offer price, citing the discount to asset value then as “simply too large to ignore”.


Baidu announced a US$5 billion share buyback after reporting better-than-expected revenue, reflecting how its cloud computing service is offsetting an advertising lull during China’s economic downturn. Its shares gained 6 per cent in pre-market US trading. Sales slipped to 33.1 billion yuan (S$6.43 billion) for the three months ended December, compared with expectations for 32.1 billion yuan. Net income came in at almost 5 billion yuan during the quarter, when China made a U-turn on its Covid Zero policy that disrupted parts of the world’s No 2 economy.

Facebook-parent Meta Platforms is planning a fresh round of job cuts in a reorganisation and downsizing effort that could affect thousands of workers, the Washington Post reported on Wednesday (Feb 22). The company did not immediately respond to a Reuters request for comment. Last year, the social media giant said it will let go of 13 per cent of its workforce, or more than 11,000 employees, as it grappled with soaring costs and a weak advertising market.

Amazon.com says it has completed its purchase of One Medical parent 1Life Healthcare, sealing the US$3.49 billion acquisition after the US Federal Trade Commission (FTC) declined to challenge it. The deal gives the e-commerce giant a network of primary-care doctors, Amazon’s biggest move to date into the health care industry. One Medical operates more than 200 medical offices in 26 markets in the US. Customers pay a subscription fee for access to its physicians and digital health services.

Intel, the biggest maker of computer processors, slashed its dividend payment to the lowest level in 16 years to preserve cash and focus on a turnaround effort. The company will reduce it’s quarterly payout to investors to 12.5 cents a share for holders payable Jun 1, the chipmaker said in a statement on Wednesday (Feb 22). Intel’s current quarterly dividend is 36.5 cents and was projected to cost more than US$6 billion in 2023. The new payment resets Intel’s dividend to a level not seen since 2007.

Tesla has begun assembling batteries in Germany but will focus cell production in the US in light of Inflation Reduction Act tax incentives, a spokesperson said, one of the first firms to declare a strategy shift prompted by the package. The US electric-vehicle maker is also preparing to produce cell components such as electrodes, some of which will be sent from its site in Gruenheide in the state of Brandenburg, to the United States, the Tesla spokesperson said on Wednesday (Feb 22).

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


PSR Stocks Coverage



For more information, please visit:


Upcoming Webinars

Guest Presentation by First REIT Management Limited [NEW]

Date: 23 February 2023

Time: 12pm – 1pm

Register: https://bit.ly/3GY2tp8

Guest Presentation by Cromwell European REIT[NEW]

Date: 28 February 2023

Time: 12pm – 1pm

Register: https://bit.ly/3xw5GYW

POEMS Podcast:

Research Videos

Weekly Market Outlook: Airbnb, PayPal, DBS, Silverlake Axis, Prime US REIT, BRC Asia & More…
Date: 20 February 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.


Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!


The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com